$2.62 Billion is the total value of Redmile Group, LLC's 71 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $321,080,000 | -36.1% | 12,957,222 | 0.0% | 12.26% | -21.8% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $237,986,000 | +12.5% | 22,158,891 | -0.8% | 9.09% | +37.7% |
| SGEN | Buy | SEAGEN INC | $151,109,000 | +137.7% | 854,013 | +93.5% | 5.77% | +190.8% |
| ARGX | Sell | ARGENX SEsponsored adr | $146,179,000 | -10.1% | 385,818 | -25.2% | 5.58% | +9.9% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $124,658,000 | +3.2% | 1,898,545 | +4.6% | 4.76% | +26.2% |
| LIVN | Sell | LIVANOVA PLC | $101,436,000 | -37.1% | 1,623,762 | -17.6% | 3.87% | -23.0% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $72,846,000 | – | 913,319 | +100.0% | 2.78% | – |
| BEAM | Buy | BEAM THERAPEUTICS INC | $71,609,000 | -31.9% | 1,849,887 | +0.8% | 2.73% | -16.7% |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $66,696,000 | -25.5% | 5,186,348 | -2.2% | 2.55% | -8.9% |
| REPL | Sell | REPLIMUNE GROUP INC | $63,720,000 | +1.7% | 3,645,309 | -1.2% | 2.43% | +24.3% |
| IGMS | IGM BIOSCIENCES INC | $60,118,000 | -32.5% | 3,334,355 | 0.0% | 2.30% | -17.5% | |
| ADCT | Buy | ADC THERAPEUTICS SA | $59,721,000 | -45.3% | 7,512,029 | +1.1% | 2.28% | -33.1% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $55,815,000 | -19.9% | 2,070,288 | +1.2% | 2.13% | -2.1% |
| CNC | Buy | CENTENE CORP DEL | $55,119,000 | +0.9% | 651,447 | +0.4% | 2.10% | +23.5% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $51,334,000 | -53.6% | 2,607,130 | -0.3% | 1.96% | -43.3% |
| XENE | New | XENON PHARMACEUTICALS INC | $49,869,000 | – | 1,639,344 | +100.0% | 1.90% | – |
| RGNX | Buy | REGENXBIO INC | $49,515,000 | -24.5% | 2,004,663 | +1.4% | 1.89% | -7.7% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $48,631,000 | -16.2% | 6,242,756 | -0.1% | 1.86% | +2.5% |
| IMGN | Sell | IMMUNOGEN INC | $41,135,000 | -6.2% | 9,141,045 | -0.8% | 1.57% | +14.7% |
| ANTM | Buy | ELEVANCE HEALTH INC | $40,530,000 | -0.8% | 83,987 | +1.0% | 1.55% | +21.4% |
| SCIENCE 37 HOLDINGS INC | $39,815,000 | -62.4% | 19,808,234 | 0.0% | 1.52% | -54.1% | ||
| MDVL | Buy | MEDAVAIL HOLDINGS INC | $38,545,000 | +258.4% | 25,192,751 | +127.5% | 1.47% | +338.1% |
| NRIX | Sell | NURIX THERAPEUTICS INC | $38,095,000 | -9.9% | 3,006,684 | -0.4% | 1.46% | +10.2% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $38,067,000 | -2.2% | 2,720,996 | -0.4% | 1.45% | +19.7% |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $35,451,000 | -6.0% | 4,521,825 | +32.8% | 1.35% | +14.9% |
| VERV | Sell | VERVE THERAPEUTICS INC | $28,017,000 | -33.1% | 1,833,547 | -0.1% | 1.07% | -18.1% |
| ABSCI CORPORATION | $26,663,000 | -60.6% | 8,031,094 | 0.0% | 1.02% | -51.8% | ||
| STOK | Sell | STOKE THERAPEUTICS INC | $26,331,000 | -38.2% | 1,993,268 | -1.5% | 1.00% | -24.4% |
| AUGX | AUGMEDIX INC | $25,885,000 | -38.8% | 14,380,327 | 0.0% | 0.99% | -25.2% | |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $24,861,000 | – | 300,000 | +100.0% | 0.95% | – |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $24,583,000 | +13.8% | 3,069,001 | -0.4% | 0.94% | +39.3% |
| ENTRADA THERAPEUTICS INC | $23,805,000 | +29.7% | 1,954,419 | 0.0% | 0.91% | +58.6% | ||
| STTK | SHATTUCK LABS INC | $22,817,000 | -4.7% | 5,619,914 | 0.0% | 0.87% | +16.6% | |
| OSH | Buy | OAK STR HEALTH INC | $22,747,000 | -29.7% | 1,383,619 | +15.0% | 0.87% | -14.0% |
| ZYME | Buy | ZYMEWORKS INC | $20,330,000 | +46.8% | 3,835,818 | +81.4% | 0.78% | +79.6% |
| PRTA | PROTHENA CORP PLC | $19,987,000 | -25.8% | 736,175 | 0.0% | 0.76% | -9.2% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $18,817,000 | +205.3% | 1,430,917 | +115.2% | 0.72% | +274.5% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $18,688,000 | -39.8% | 3,403,926 | +41.4% | 0.71% | -26.3% |
| NVRO | Sell | NEVRO CORP | $17,774,000 | -40.2% | 405,517 | -1.3% | 0.68% | -26.8% |
| Sell | STEVANATO GROUP S P A | $17,641,000 | -23.8% | 1,115,825 | -3.0% | 0.67% | -6.6% | |
| GRTS | Buy | GRITSTONE BIO INC | $16,826,000 | -40.6% | 6,952,760 | +1.2% | 0.64% | -27.4% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $15,000,000 | -34.0% | 1,587,285 | -0.9% | 0.57% | -19.3% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $14,925,000 | -9.3% | 817,832 | +9.2% | 0.57% | +10.9% |
| ISEE | Buy | IVERIC BIO INC | $14,612,000 | -41.6% | 1,518,900 | +2.2% | 0.56% | -28.6% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $14,550,000 | -18.6% | 93,264 | -18.7% | 0.56% | -0.4% |
| ANNX | Buy | ANNEXON INC | $13,207,000 | +51.0% | 3,503,190 | +9.4% | 0.50% | +84.6% |
| NUVB | NUVATION BIO INC | $11,248,000 | -38.4% | 3,471,709 | 0.0% | 0.43% | -24.7% | |
| TNDM | Sell | TANDEM DIABETES CARE INC | $11,096,000 | -64.8% | 187,460 | -30.9% | 0.42% | -57.0% |
| Sell | SOMALOGIC INC | $9,441,000 | -69.9% | 2,088,639 | -46.5% | 0.36% | -63.2% | |
| NVTA | INVITAE CORP | $9,285,000 | -69.4% | 3,805,403 | 0.0% | 0.36% | -62.5% | |
| BVS | Buy | BIOVENTUS INC | $8,909,000 | -51.3% | 1,306,339 | +0.7% | 0.34% | -40.5% |
| Sell | THE ONCOLOGY INSTITUTE INC | $8,785,000 | -49.0% | 1,736,116 | -28.1% | 0.34% | -37.6% | |
| LVTX | LAVA THERAPEUTICS NV | $8,054,000 | -35.0% | 2,816,196 | 0.0% | 0.31% | -20.4% | |
| ALLK | Sell | ALLAKOS INC | $7,967,000 | -45.4% | 2,545,275 | -0.6% | 0.30% | -33.3% |
| HOOK | Sell | HOOKIPA PHARMA INC | $7,436,000 | -29.7% | 4,562,248 | -1.6% | 0.28% | -13.9% |
| ADAGIO THERAPEUTICS INC | $6,301,000 | -28.1% | 1,920,960 | 0.0% | 0.24% | -11.7% | ||
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $6,203,000 | -52.5% | 766,797 | -0.7% | 0.24% | -41.8% |
| PRVA | New | PRIVIA HEALTH GROUP INC | $6,002,000 | – | 206,113 | +100.0% | 0.23% | – |
| TKNO | ALPHA TEKNOVA INC | $4,770,000 | -39.2% | 567,800 | 0.0% | 0.18% | -25.7% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $4,052,000 | -14.3% | 1,608,089 | 0.0% | 0.16% | +4.7% | |
| IMTX | Sell | IMMATICS N.V | $3,917,000 | -32.4% | 449,661 | -38.0% | 0.15% | -17.1% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $3,540,000 | -45.7% | 3,436,935 | -0.8% | 0.14% | -33.5% |
| ALVR | ALLOVIR INC | $3,211,000 | -42.2% | 823,371 | 0.0% | 0.12% | -28.9% | |
| TCRR | TCR2 THERAPEUTICS INC | $3,174,000 | +5.1% | 1,094,645 | 0.0% | 0.12% | +28.7% | |
| STXS | STEREOTAXIS INC | $2,737,000 | -50.7% | 1,487,495 | 0.0% | 0.10% | -39.3% | |
| XERIS BIOPHARMA HOLDINGS INC | $1,612,000 | -39.8% | 1,046,587 | 0.0% | 0.06% | -26.2% | ||
| BCEL | ATRECA INC | $1,433,000 | -43.5% | 800,306 | 0.0% | 0.06% | -30.4% | |
| SONENDO INC | $857,000 | -57.1% | 498,131 | 0.0% | 0.03% | -46.8% | ||
| CABA | CABALETTA BIO INC | $738,000 | -47.8% | 696,377 | 0.0% | 0.03% | -36.4% | |
| CTSO | CYTOSORBENTS CORP | $583,000 | -31.4% | 266,365 | 0.0% | 0.02% | -18.5% | |
| AYLA | Sell | AYALA PHARMACEUTICALS INC | $372,000 | -79.2% | 341,030 | -24.2% | 0.01% | -75.0% |
| EPZM | Exit | EPIZYME INC | $0 | – | -454,475 | -100.0% | -0.02% | – |
| ICUI | Exit | ICU MED INC | $0 | – | -96,869 | -100.0% | -0.67% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -53,445 | -100.0% | -0.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.